当前位置:药药网 / 数据中心 /靶点信息(本栏目收费,不能显示细节,电话13136136841)
靶点信息62(本栏目收费,不能显示细节,电话13136136841)
靶点信息
TARGNAME
Transforming growth factor beta 2 (TGFB2)
TARGTYPE
Clinical trial target
SYNONYMS
Transforming growth factor beta-2 proprotein; TGF-beta 2; Polyergin; Glioblastoma-derived T-cell suppressor factor; G-TSF; Cetermin; BSC-1 cell growth inhibitor
FUNCTION
Transforming growth factor beta-2 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-2 (TGF-beta-2) chains, which constitute the regulatory and active subunit of TGF-beta-2, respectively.
PDBSTRUC
5TY4; 5TX4; 4KXZ; 2TGI; 1TFG
SEQUENCE
MHYCVLSAFLILHLVTVALSLSTCSTLDMDQFMRKRIEAIRGQILSKLKLTSPPEDYPEPEEVPPEVISIYNSTRDLLQEKASRRAAACERERSDEEYYAKEVYKIDMPPFFPSENAIPPTFYRPYFRIVRFDVSAMEKNASNLVKAEFRVFRLQNPKARVPEQRIELYQILKSKDLTSPTQRYIDSKVVKTRAEGEWLSFDVTDAVHEWLHHKDRNLGFKISLHCPCCTFVPSNNYIIPNKSEELEARFAGIDGTSTYTSGDQKTIKSTRKKNSGKTPHLLLMLLPSYRLESQQTNRRKKRALDAAYCFRNVQDNCCLRPLYIDFKRDLGWKWIHEPKGYNANFCAGACPYLWSSDTQHSRVLSLYNTINPEASASPCCVSQDLEPLTILYYIGKTPKIEQLSNMIVKSCKCS
KEGGPATH
hsa04010:MAPK signaling pathway
KEGGPATH
hsa04060:Cytokine-cytokine receptor interaction
KEGGPATH
hsa04068:FoxO signaling pathway
KEGGPATH
hsa04110:Cell cycle
KEGGPATH
hsa04144:Endocytosis
KEGGPATH
hsa04350:TGF-beta signaling pathway
KEGGPATH
hsa04380:Osteoclast differentiation
目标的 KEGG 通路数据
| 标题 | 内容 |
| hsa05220 |
|
| hsa05321 |
|
| hsa05323 |
|
| hsa05410 |
|
| hsa05414 |
|
| hsa04010 |
|
| hsa04060 |
|
| hsa04068 |
|
| hsa04110 |
|
| hsa04144 |
|
| hsa04350 |
|
| hsa04380 |
|
| hsa04390 |
|
| hsa05140 |
|
| hsa05142 |
|
| hsa05144 |
|
| hsa05145 |
|
| hsa05146 |
|
| hsa05152 |
|
| hsa05161 |
|
| hsa05166 |
|
| hsa05200 |
|
| hsa05205 |
|
| hsa05206 |
|
| hsa05210 |
|
| hsa05211 |
|
| hsa05212 |
|
目标的 Wiki 路径数据
| 标题 | 内容 |
| WP400 |
|
| WP382 |
|
| WP2884 |
|
| WP2882 |
|
| WP2877 |
|
| WP2870 |
|
| WP2703 |
|
| WP2666 |
|
| WP474 |
|
目标的蛋白质ID
| 标题 | 内容 |
| TARGETID |
|
| UNIPROID |
|
| TARGNAME |
|
| TARGTYPE |
|
目标的序列数据
| 标题 | 内容 |
| Transforming growth factor beta 2 (TGFB2) |
|